Study of Lipid Mediators in Chronic Postoperative Pain - LICP
This interventional prospective study aims firstly to investigate variations in lipid levels in blood samples and their potential relationship with the duration and/or intensity of post-operative pain. Secondly, it aims to investigate the activation of peripheral blood mononuclear cells and neutrophils in patient blood samples. The study will enrol women aged 18 years or older who have been newly diagnosed with primary invasive or non-invasive breast cancer requiring surgical removal of the tumour, with or without…
Conditions studied
Breast Cancer Female, Postoperative Pain
About this study
This interventional prospective study aims firstly to investigate variations in lipid levels in blood samples and their potential relationship with the duration and/or intensity of post-operative pain. Secondly, it aims to investigate the activation of peripheral blood mononuclear cells and neutrophils in patient blood samples. The study will enrol women aged 18 years or older who have been newly diagnosed with primary invasive or non-invasive breast cancer requiring surgical removal of the tumour, with or without axillary surgery. The main objectives of the study are To assess whether there is an association between circulating levels of lipid mediators and chronicity (\> 3 months) of postoperative pain after breast cancer surgery. To assess whether circulating levels of lipid mediators can predict chronicity of postoperative pain in breast cancer surgery. To assess the existence of an association between resected tissue levels of lipid mediators and chronicity of postoperative pain in breast cancer surgery. To assess whether tissue levels of lipid mediators can predict chronicity of postoperative pain in breast cancer surgery.
Interventions
- Other: Blood sample + questionnaire — * blood sample before tumor surgery and at every follow-up visit * questionnaire before tumor surgery and at every follow-up visit
Primary outcomes
- Pain intensity (Throughout the study, an average of 2 years)
- Pain duration (Throughout the study, an average of 2 years)
- Lipid Mediator Levels in Blood (Throughout the study, an average of 2 years)
Eligibility information
Study locations
- Cliniques universitaires Saint-Luc (UCLouvain), Brussels, Brussels Capital 1200 Belgium
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-09.